Skip to main content
. 2013 Jul 20;31(9):807–822. doi: 10.1007/s40273-013-0076-z

Fig. 3.

Fig. 3

Cost-effectiveness plane—incremental costs and effects for DFP vs comparators. Each point represents a simulation, while the dotted line represents the cost-effectiveness threshold (£20,000/QALY); combination is DFO–DFP. DFO desferrioxamine, DFP deferiprone, DFX deferasirox, QALY quality-adjusted life year